JCR Pharmaceuticals Co., Ltd. Clinical Trial Pipeline: 8 Active Trials, 2 Changes This Month

What changed in the last 30 days

2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.

Show 1 trial with minor changes only

Stopped: an ongoing trial was terminated, suspended or withdrawn.
Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

NCT ID	Title	Condition	Status	Updated
Phase 3
NCT04573023	A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)	Mucopolysaccharidosis II	Active, Not Recruiting	2026-10-02
NCT05594992	An Extension Study of JR-141 to Evaluate the Long-term Safety and Efficacy in MPS II…	Mucopolysaccharidosis II	Enrolling by Invitation	2026-01-21
Phase 2/3
NCT04348136	An Extension Study of JR-141 in Patients With Mucopolysaccharidosis Type II	Mucopolysaccharidosis II	Active, Not Recruiting	2026-09-03
Phase 2
NCT03708965	An Extension Study of JR-141-BR21 in Patients With Mucopolysaccharidosis II	Mucopolysaccharidosis II	Active, Not Recruiting	2026-09-08
Phase 1/2
NCT07640984	A Phase I/II Trial of JR-446 in Mucopolysaccharidosis Type IIIB (MPS IIIB)	Mucopolysaccharidosis IIIB	Recruiting	2026-09-21
NCT06488924	An Open-label Phase I/II Study of JR-446 in Mucopolysaccharidosis Type IIIB	Mucopolysaccharidosis III-B	Active, Not Recruiting	2026-10-01
NCT06095388	Phase I/II Study of JR-441 in Patients With Mucopolysaccharidosis Type IIIA	Mucopolysaccharidosis III-A	Active, Not Recruiting	2026-09-04
Not specified
NCT07615400	A Long-Term Observational Study of Patients With Fucosidosis	Fucosidosis	Recruiting	2026-09-17